PharmaShots | Incisive News in 3 Shots

Subscribe Now

esSCLC

Bristol-Myers' Opdivo and Yervoy Combination Couldn't Meet OS as Maintenance Therapy in esSCLC Patients Post 1L Chemo

Bristol-Myers' Opdivo and Yervoy Combination Couldn't Meet OS as Maintenance Therapy in esSCLC Patients Post 1L Chemo

November 27, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us